1. "Journal of Clinical Oncology"
  2. "Urology"
Formats
  1. Meeting Abstract (254)
  2. Journal Article (116)
  3. Correspondence (1)
  4. Guidelines (1)
Groups
  1. Surgery (372)
  2. Urology (372)
  3. Department of Medicine (226)
  4. Solid Tumor Oncology Division (224)
  5. Genitourinary Oncology Service (222)
  6. Survivorship Research (141)

More Groups

People
  1. Dean Bajorin (110)
  2. Robert Motzer (100)
  3. Bernard Bochner (69)
  4. Peter Scardino (64)
  5. George Bosl (61)
  6. Joel Sheinfeld (59)

More People

Years
  1. 2023 (15)
  2. 2022 (16)
  3. 2021 (16)
  4. 2020 (21)
  5. 2019 (19)
  6. 2018 (21)

More Years

Publications
  1. Journal of Clinical Oncology (372)
Publishers
  1. American Society of Clinical Oncology (372)

Results (372)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 3 multicenter study to evaluate the safety and efficacy of padeliporfin vascular targeted photodynamic therapy (VTP) in treatment of low-grade (LG) upper tract urothelial cancer (UTUC)
    Meeting Abstract

    Coleman, J.; Margulis, V.; Scherz, A. J.; Krasnopolskaya, I.; Alpert, G.; Jobert, V.; Preise, D.; Shore, N. D.; UCM301 Investigators
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • An in-progress phase 2 window of opportunity (WOO) trial of targeted therapy with erdafitinib for patients with recurrent FGFR3-altered non–muscle-invasive bladder cancer (NMIBC)
    Meeting Abstract

    Dsouza, N.; Gaffney, C.; Hernandez, C.; Moran, P.; Worth, K.; McCarter, M.; de Jesus, M. R.; Solit, D. B.; Sarungbam, J.; Al-Ahmadie, H. A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A brief mind-body intervention to reduce pain and anxiety during prostate needle biopsy: A randomized, controlled trial with two-staged consent
    Meeting Abstract

    Gaffney, C.; Vertosick, E. E.; Carlsson, S. V.; Lin, X.; Wolchasty, N.; Hardbattle, R.; Vickers, A.; Ehdaie, B.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Post radical prostatectomy (RP) PSA outcomes following 6 vs 18 months of perioperative androgen deprivation therapy (ADT) in men with localized high risk prostate cancer (LHRPC): Results of Part 2 of a randomized phase 2 trial
    Meeting Abstract

    McKay, R. R.; Xie, W.; Yang, X.; Rathkopf, D. E.; Laudone, V. P.; Bubley, G.; Einstein, D. J.; Chang, P.; Wagner, A.; Kane, C. J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The performance of prostate specific antigen (PSA) testing in the population based NPCC cohort
    Meeting Abstract

    Oldenburg, J.; Bjerner, J. L.; Pasovic, L.; Müller, S.; Fossa, S. D.; Carlsson, S. V.; Albertsen, P. C.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Mismatch repair deficiency and microsatellite instability-high in urothelial carcinoma: A systematic review and meta-analysis
    Meeting Abstract

    Chandran, E.; Iannantuono, G. M.; Akbulut, D.; Atiq, S. O.; Gurram, S.; Teo, M. Y.; Coleman, J.; Sinaii, N.; Apolo, A. B.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Adjuvant nivolumab plus ipilimumab vs placebo for patients with localized renal cell carcinoma at high risk of relapse after nephrectomy: Subgroup analyses from the phase 3 CheckMate 914 (part A) trial
    Meeting Abstract

    Motzer, R. J.; Russo, P.; Grünwald, V.; Tomita, Y.; Barthélémy, P.; Goh, J. C.; Cutuli, H. J.; Simsek, B.; Spiridigliozzi, J.; Chudnovsky, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Multicenter phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma
    Journal Article

    Coleman, J. A.; Yip, W.; Wong, N. C.; Sjoberg, D. D.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Cha, E. K.; Donahue, T. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II trial of intravesical chemoimmunotherapy with gemcitabine and bacillus Calmette-Guérin (BCG) for patients with BCG-exposed, high-grade, non-muscle–invasive bladder cancer
    Meeting Abstract

    Gaffney, C.; Dsouza, N.; Hernandez, C.; McCarter, M.; Moran, P.; Stasi, K.; Worth, K.; Dalbagni, G.; Donahue, T. F.; Donat, S. M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and immunogenomic outcomes of consolidative cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immune checkpoint blockade
    Meeting Abstract

    Reese, S. W.; Jiang, H.; Kuo, F.; Wu, C. Y.; Vuong, L.; Mascareno, E.; Oparanozie, A.; Motzer, R. J.; Voss, M. H.; Reznik, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save